Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...
ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...
UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. A live question and answer session ...
ProPhase Labs, Inc. (PRPH) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.23 per share a year ago. These ...
UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH), a microcap healthcare company with a market value of $18.69 million, announced Tuesday that its three COVID-19 testing laboratory subsidiaries have ...
ProPhase Labs’s stock price closed at $0.44. It is down -50.000% in the last 3 months and down -94.010% in the last 12 months. ProPhase Labs saw 1 positive EPS revisions and 1 negative EPS revisions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results